Literature DB >> 22019616

Social egg freezing: for better, not for worse.

Heidi Mertes1, Guido Pennings.   

Abstract

The possibility for healthy women to cryopreserve their oocytes in order to counter future infertility has gained momentum in recent years. However, women tend to cryopreserve oocytes at an age that is suboptimal from a clinical point of view--in their late thirties--when both oocyte quantity and quality have already considerably diminished and success rates for eventually establishing a pregnancy are thus limited. This also gives rise to ethical concerns, as the procedure is seen as giving false hope to (reproductively speaking) older women. This study evaluates which measures can be taken to turn social freezing into a procedure that is both clinically and ethically better than the current practice. The main objective of these measures is to convince those women who are most likely to (want to) reproduce at an above-average age to cryopreserve their oocytes at a time when this intervention is still likely to lead to a live birth and to discourage fertility clinics from specifically targeting women who have already surpassed the age at which good results can be expected. The possibility for healthy women to cryopreserve their oocytes in order to counter future infertility has gained momentum in recent years. However, women tend to cryopreserve oocytes at a time that is suboptimal from a clinical point of view - in their late thirties - when both oocyte quantity and quality have already considerably diminished and success rates for eventually establishing a pregnancy are thus limited. This also gives rise to ethical concerns, as the procedure is seen as giving false hope to (reproductively speaking) older women. We evaluate which measures can be taken to turn social freezing into a procedure that is both clinically and ethically better than the current practice and discern three different steps: creating public awareness; offering individualized, age-specific information and counselling; and offering predictive tests such as anti-Müllerian hormone measurements or antral follicle count. The main objective of these measures is to convince those women who are most likely to benefit from social freezing to present themselves before age 35 and to discourage fertility clinics from specifically targeting women who have already surpassed the age at which good results can be expected.
Copyright © 2011 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22019616     DOI: 10.1016/j.rbmo.2011.09.010

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  24 in total

1.  A comparison of live birth rates and perinatal outcomes between cryopreserved oocytes and cryopreserved embryos.

Authors:  Jacqueline R Ho; Irene Woo; Kristin Louie; Wael Salem; Sami I Jabara; Kristin A Bendikson; Richard J Paulson; Karine Chung
Journal:  J Assist Reprod Genet       Date:  2017-07-17       Impact factor: 3.412

2.  Does company-sponsored egg freezing promote or confine women's reproductive autonomy?

Authors:  Heidi Mertes
Journal:  J Assist Reprod Genet       Date:  2015-05-24       Impact factor: 3.412

3.  Preserving children's fertility: two tales about children's right to an open future and the margins of parental obligations.

Authors:  Daniela Cutas; Kristien Hens
Journal:  Med Health Care Philos       Date:  2015-05

4.  For whom the egg thaws: insights from an analysis of 10 years of frozen egg thaw data from two UK clinics, 2008-2017.

Authors:  Zeynep B Gürtin; Lucy Morgan; David O'Rourke; Jinjun Wang; Kamal Ahuja
Journal:  J Assist Reprod Genet       Date:  2019-05-23       Impact factor: 3.412

5.  Oocyte cryopreservation beyond cancer: tools for ethical reflection.

Authors:  Alma Linkeviciute; Fedro A Peccatori; Virginia Sanchini; Giovanni Boniolo
Journal:  J Assist Reprod Genet       Date:  2015-07-03       Impact factor: 3.412

6.  Medical and elective fertility preservation: impact of removal of the experimental label from oocyte cryopreservation.

Authors:  Samantha B Schon; Maren Shapiro; Clarisa Gracia; Suneeta Senapati
Journal:  J Assist Reprod Genet       Date:  2017-06-27       Impact factor: 3.412

7.  Attitudes towards Social Oocyte Freezing from a Socio-cultural Perspective.

Authors:  Maren Schick; Réka Sexty; Beate Ditzen; Tewes Wischmann
Journal:  Geburtshilfe Frauenheilkd       Date:  2017-07-17       Impact factor: 2.915

8.  Awareness, knowledge, and perceptions of infertility, fertility assessment, and assisted reproductive technologies in the era of oocyte freezing among female and male university students.

Authors:  C Meissner; C Schippert; Frauke von Versen-Höynck
Journal:  J Assist Reprod Genet       Date:  2016-04-28       Impact factor: 3.412

Review 9.  Current trends and progress in clinical applications of oocyte cryopreservation.

Authors:  Aylin P Cil; Emre Seli
Journal:  Curr Opin Obstet Gynecol       Date:  2013-06       Impact factor: 1.927

10.  Let us talk about eggs! Professional resistance to elective egg vitrification and gendered medical paternalism.

Authors:  Judit Sándor; Lilla Vicsek; Zsófia Bauer
Journal:  Med Health Care Philos       Date:  2018-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.